Predatory Journals in Orthopaedic Surgery.

J Am Acad Orthop Surg · Feb 15 2023 · Review

Kachooei A, Bachoura A, Hirsch D, Beredjiklian PK

From the Rothman Orthopaedic Institute, Philadelphia, PA

General Orthopaedics

SUMMARY — THE REDUCTIONReview of predatory journals in orthopaedics, which publish without real peer review for a fee, explaining how they solicit authors and offering ways for authors and readers to identify and avoid them.
Abstract, as published

The prevalence of predatory journals in orthopaedic surgery continues to increase. These journals directly solicit authors, offering the advantages of open access and quick publication rates. Solicitation typically occurs in the form of e-mail communications, and the targets are usually identified as authors who have published other works in conventional publications. These predatory journals process manuscripts without peer review and plagiarism checks and often for a substantial publication fee. As a result, the scientific value of these publications is grossly suspect and has been considered a substantial threat to the quality of scientific discourse and scholarship. This affects not only the layperson reading the works but also investigators tricked into publishing in these venues. It has been estimated that several million US dollars per year are spent on these publications and, in many instances, using monies granted by agencies such as the National Institutes of Health. This review aims to study the types of solicitation, evaluate the increasing prevalence in orthopaedic surgery, and offer methods to authors and readers to identify these journals to mitigate their negative effects.

Featured in the 2026-10-08 issue.

← The Optimum Pore Size for the Fixation of Porous-Surfaced Met…The Effect of Adverse Events on Orthopaedic Surgeons: A Review. →

The Reduction is a free email digest of newly published orthopaedic literature — a handful of new papers in the subspecialties you choose, each summarized like this one. Subscribe free or browse the archive.